Neuropsychotoxic and Neuroprotective Potentials of Dextromethorphan and Its Analogs

被引:32
作者
Shin, Eun-Joo [1 ]
Bach, Jae-Hyung [1 ]
Lee, Sung Youl [1 ]
Kim, Jeong Min [2 ]
Lee, Jinhwa [2 ]
Hong, Jau-Shyong [3 ]
Nabeshima, Toshitaka [4 ]
Kim, Hyoung-Chun [1 ]
机构
[1] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea
[2] Green Cross Co, Cent Res Ctr, Yongin 446799, South Korea
[3] NIEHS, Neuropharmacol Sect, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA
[4] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Nagoya, Aichi 4688503, Japan
基金
新加坡国家研究基金会;
关键词
dextromethorphan; dimemorfan; 3-hydroxymorphinan; neuroprotection; neuropsychotoxicity; neurodegenerative disorder; METHYL-D-ASPARTATE; NMDA RECEPTOR ANTAGONISTS; EXCITATORY AMINO-ACIDS; LONG-TERM POTENTIATION; POSTOPERATIVE PAIN; INDUCED SEIZURES; BINDING-SITES; RAT-BRAIN; DEXTRORPHAN; DIMEMORFAN;
D O I
10.1254/jphs.11R02CR
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dextromethorphan (3-methoxy-17-methylmorphinan) has complex pharmacologic effects on the central nervous system. Although some of these effects are neuropsychotoxic, this review focuses on the neuroprotective effects of dextromethorphan and its analogs. Some of these analogs, particularly dimemorfan (3-methyl-17-methylmorphinan) and 3-hydroxymorphinan, have promising neuroprotective properties with negligible neuropsychotoxic effects. Their neuroprotective effects, the mechanisms underlying these effects, and their therapeutic potential for the treatment of diverse neurodegenerative disorders are discussed.
引用
收藏
页码:137 / 148
页数:12
相关论文
共 100 条
[1]  
AANONSEN LM, 1987, J PHARMACOL EXP THER, V243, P9
[2]  
ARAM JA, 1989, J PHARMACOL EXP THER, V248, P320
[3]  
Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554
[4]   Adverse effects of dextromethorphan on the spatial learning of rats in the Morris water maze [J].
Bane, A ;
Rojas, D ;
Indermaur, K ;
Bennett, T ;
Avery, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 302 (1-3) :7-12
[5]   COEXISTENCE OF GLUTAMATE AND SUBSTANCE-P IN DORSAL-ROOT GANGLION NEURONS OF THE RAT AND MONKEY [J].
BATTAGLIA, G ;
RUSTIONI, A .
JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 277 (02) :302-312
[6]   DEXTROMETHORPHAN - AN OVERVIEW OF SAFETY ISSUES [J].
BEM, JL ;
PECK, R .
DRUG SAFETY, 1992, 7 (03) :190-199
[7]   REGIONAL DISTRIBUTION OF SUBSTANCE-P WITHIN AMYGDALOID COMPLEX AND BED NUCLEUS OF STRIA TERMINALIS [J].
BENARI, U ;
LASALLE, GLG ;
KANAZAWA, I .
NEUROSCIENCE LETTERS, 1977, 4 (06) :299-302
[8]   DEXTROMETHORPHAN INHIBITS ISCHEMIA-INDUCED C-FOS EXPRESSION AND DELAYED NEURONAL DEATH IN HIPPOCAMPAL-NEURONS [J].
BOKESCH, PM ;
MARCHAND, JE ;
CONNELLY, CS ;
WURM, WH ;
KREAM, RM .
ANESTHESIOLOGY, 1994, 81 (02) :470-477
[9]   DEXTROMETHORPHAN AND PARKINSONISM [J].
BONUCCELLI, U ;
DELDOTTO, P ;
PICCINI, P ;
BEHGE, F ;
CORSINI, GU ;
MURATORIO, A .
LANCET, 1992, 340 (8810) :53-53
[10]   Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats [J].
Britton, P ;
Lu, XCM ;
Laskosky, MS ;
Tortella, FC .
LIFE SCIENCES, 1997, 60 (20) :1729-1740